Новини фондового ринку
Останні фінансові новини · Оновлено Лип 28, 2026
Citi залишається оптимістичним щодо Veradermics, Incorporated (MANE)
Citi Remains Bullish on Veradermics, Incorporated (MANE)
The panel is divided on MANE's potential. While some see promise in its Phase 2/3 Part A data and the …
Ripple (XRP) уклала 10 великих угод цього року: ось таблиця результатів кожного партнерства
Ripple (XRP) Has Closed 10 Major Deals This Year: Here’s the Scoreboard for Each Partnership
Despite Ripple's infrastructure wins, XRP's price performance remains lackluster due to regulatory uncertainty and limited token utility. The market is …
JPMorgan рекомендує купувати акції Erasca (ERAS) за поточними цінами
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
The panel consensus is bearish on Erasca (ERAS), with concerns around 'not fully clean' Phase 1 data, safety caveats, and …
Stifel залишається оптимістичним щодо Tango Therapeutics (TNGX)
Stifel Remains Bullish on Tango Therapeutics (TNGX)
The panel's discussion on TNGX revolves around the potential of its PRMT5/RAS(ON) combo in pancreatic cancer, with a cash runway …
Leerink Partners підняв PT на Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …
Чи AnaptysBio (ANAB) є однією з найбільш ефективних акцій у сфері охорони здоров'я на сьогоднішній день у 2026 році?
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …
RBC Capital піднімає цільову ціну на Acadia Healthcare Company (ACHC) після перевищення квартальних прибутків Q1
RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat
While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …
Twist Bioscience Corporation (TWST) оголошує фінансові результати за 2 квартал 2026 року
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …
Goldman Sachs скидає прогноз щодо акцій Broadcom
Goldman Sachs resets Broadcom stock forecast
The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …
RBC Capital підвищує PT на CG Oncology (CGON), називає PIVOT-006 складним каталізатором
RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst
CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …
Відомості про виклик зараховань Q1 W.W. Grainger
W.W. Grainger Q1 Earnings Call Highlights
Panelists have mixed views on Grainger's Q1 results and future prospects. While some highlight the impressive EPS growth and margin …